Bruce E Johnston

Title: Bruce E Johnston: Innovator in Cancer Treatment

Introduction

Bruce E Johnston is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative methods that enhance the effectiveness of targeted therapies. With a total of 3 patents to his name, Johnston's work is pivotal in advancing medical diagnostics and treatment options.

Latest Patents

One of Johnston's latest patents is a method to determine the responsiveness of cancer to epidermal growth factor receptor (EGFR) targeting treatments. This invention focuses on identifying variances in the kinase domain of the erbB1 gene, which can indicate sensitivity to the tyrosine kinase inhibitor gefitinib. By developing a diagnostic assay for these mutations, Johnston's work allows for the administration of gefitinib, erlotinib, and other tyrosine kinase inhibitors to patients who are most likely to benefit from these drugs.

Career Highlights

Throughout his career, Bruce E Johnston has worked with esteemed organizations such as The General Hospital Corporation and Dana-Farber Cancer Institute Inc. His experience in these institutions has provided him with a robust platform to develop and refine his innovative ideas in cancer treatment.

Collaborations

Johnston has collaborated with notable colleagues in his field, including Daphne Winifred Bell and Daniel Arie Haber. These partnerships have likely contributed to the depth and impact of his research and inventions.

Conclusion

In summary, Bruce E Johnston is a distinguished inventor whose work in cancer treatment has the potential to significantly improve patient outcomes. His innovative methods and collaborations highlight his commitment to advancing medical science.